Europe Endovascular Aneurysm Repair Market Size, Share & Industry Trends Analysis Report By Indication (Abdominal and Thoratic), By Product, By Site, By Anatomy (Traditional and Complex), By Country and Growth Forecast, 2022 - 2028
Special Offering: Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support
Get in-depth analysis of the COVID-19 impact on the Europe Endovascular Aneurysm Repair Market
Market Report Description
The Europe Endovascular Aneurysm Repair Market would witness market growth of 4.6% CAGR during the forecast period (2022-2028).
The rise in the occurrence of aortic aneurysm, expansion in the geriatric population, technological improvements in EVAR, availability of attractive reimbursements for EVAR operations & equipment, and increase in the smoking population are the factors driving the endovascular aneurysm repair market growth. Furthermore, this operation carries a number of hazards, including iliac perforation, stent stenosis, aneurysmal rupture, endoleaks, and end tension. To solve such issues, several technologies have been created and introduced, resulting in market expansion. In addition, technical advancements in the endovascular aneurysm repair market companies are a source of endovascular aneurysm repair market opportunity.
A covered stent or an aortic stent would be inserted into the area of the weak artery during the minimally invasive surgery. The blood would be given a new channel, according to the operation estimate, and so would not collect, avoiding any bulging or bursting. When compared to standard open aortic surgery, the EVAR treatment provides more comfort because the patient spends less time in the hospital and recovers faster.
The NHS in Europe's Public Health England screening program is a national population screening program that identifies healthy adults who may be at risk of developing an aortic aneurysm. As a result, early treatment and informed decisions are possible. Because of the rising senior population and incidence of cardiovascular illnesses and hypertension, growing disposable income, and developing healthcare infrastructure, the region is estimated to experience a high demand for endovascular aneurysm repair across the region in the upcoming years.
An abdominal aortic aneurysm (AAA) affects about 4% of men aged 65 to 74 in England (about 80,000 men), resulting in roughly 6000 fatalities each year in England and Wales. AAA is responsible for approximately 2% of all fatalities in males aged 65 and up. Abdominal aortic aneurysms are substantially less common in women. Men are nearly three times as likely as women to have them. The UK also has a fairly developed healthcare system due to large amount of investment by the government.
The Germany market dominated the Europe Endovascular Aneurysm Repair Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $241.2 million by 2028. The UK market is experiencing a CAGR of 3.7% during (2022 - 2028). Additionally, The France market would exhibit a CAGR of 5.4% during (2022 - 2028).
Based on Indication, the market is segmented into Abdominal and Thoratic. Based on Product, the market is segmented into Percutaneous Evar, Fenestrated Evar, Aortic Stents & Taa Graft, and Others. Based on Site, the market is segmented into Infrarenal and Pararenal. Based on Anatomy, the market is segmented into Traditional and Complex. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Endologix LLC, Lombard Medical Limited, Cardinal Health, Inc., Becton, Dickinson and Company, Medtronic PLC, Cook Medical, Inc., Koninklijke Philips N.V., Terumo Corporation, Abbott Laboratories, and Artivion, Inc.
Scope of the Study
Market Segments Covered in the Report:
- Percutaneous Evar
- Fenestrated Evar
- Aortic Stents & Taa Graft
- Rest of Europe
Key Market Players
List of Companies Profiled in the Report:
- Endologix LLC
- Lombard Medical Limited
- Cardinal Health, Inc.
- Becton, Dickinson and Company
- Medtronic PLC
- Cook Medical, Inc.
- Koninklijke Philips N.V.
- Terumo Corporation
- Abbott Laboratories
- Artivion, Inc.
Unique Offerings from KBV Research
- Exhaustive coverage
- The highest number of market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free